Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, CFG

Notice to the media - Government of Canada officials to hold a technical briefing on the roll-out of COVID-19 vaccines


OTTAWA, ON, Dec. 3, 2020 /CNW/ - Government of Canada officials will hold a technical briefing to provide an overview on the roll-out of COVID-19 vaccines.

Date
December 3, 2020

Time
12:00 PM (EST)

Location
Sir John A Macdonald Building, Room 200
144 Wellington Street, Ottawa, Ontario

The media availability will also be held by teleconference.

Toll-free (Canada/US) dial-in number:
1-866-206-0153

Local dial-in number:
613-954-9003

Passcode:     1622050#

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 22:45
Syros Pharmaceuticals , a leader in the development of medicines that control the expression of genes, announced today that it has priced an underwritten public offering of 5,400,000 shares of common stock at a public offering price of $14.00 per...

at 21:42
BioLineRx Ltd. , a late clinical-stage biopharmaceutical company focused on oncology, today announced that due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis...

at 21:33
Genesis MedTech Group has reached a consensus to fully acquire Hua Medtech as part of its plans to set up a specialised neurovascular franchise, which has entered into a strategic cooperation with Penumbra, Inc., an NYSE listed, global healthcare...

at 20:55
Kiromic BioPharma, Inc. , an immuno-oncology target discovery and gene-editing company, with a proprietary artificial intelligence neural network platform (Diamond AI) to develop novel oncology therapeutics, has announced the completion and...

at 20:00
Lucid Audio® announces the launch of Engagetm? to evolve hearing healthcare as we know it. Welcome to unrivaled clarity of speech, high-resolution Bluetooth streaming, and industry-leading rechargeable technology delivered directly to your door....

at 19:00
LabMinds®, Inc., a pioneer in automation for solution preparation in life sciences, today announced that the Revo has been approved for use in a Good Manufacturing Practice (GMP) certified laboratory in a Top 10 Pharmaceutical company. LabMinds is...



News published on 3 december 2020 at 08:38 and distributed by: